As spotlight trains on biopharma diversity, most companies kept their C-suites exactly the same in 2020 — report

The past year has cast a harsh spotlight on the biopharma industry’s lack of diversity. And though most companies list diversity and inclusion as one of their key values, a whopping 67% of companies saw little or no change in representation by race or ethnicity at the executive level, according to a recent BIO survey.